Metropolitan Life Insurance Company (MetLife)’s Smith & Wesson SWBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,524
| Closed | -$43.8K | – | 1870 |
|
|
2024
Q1 | $43.8K | Sell |
2,524
-122
| -5% | -$1.76K | ﹤0.01% | 1472 |
|
|
2023
Q4 | $35.9K | Hold |
2,646
| – | – | ﹤0.01% | 1614 |
|
|
2023
Q3 | $34.2K | Buy |
2,646
+311
| +13% | +$3.88K | ﹤0.01% | 1607 |
|
|
2023
Q2 | $30.4K | Hold |
2,335
| – | – | ﹤0.01% | 1706 |
|
|
2023
Q1 | $28.7K | Sell |
2,335
-726
| -24% | -$7.77K | ﹤0.01% | 1705 |
|
|
2022
Q4 | $26.6K | Hold |
3,061
| – | – | ﹤0.01% | 1850 |
|
|
2022
Q3 | $31.7K | Hold |
3,061
| – | – | ﹤0.01% | 1763 |
|
|
2022
Q2 | $40.2K | Hold |
3,061
| – | – | ﹤0.01% | 1636 |
|
|
2022
Q1 | $46.3K | Sell |
3,061
-9,614
| -76% | -$162K | ﹤0.01% | 1645 |
|
|
2021
Q4 | $226K | Hold |
12,675
| – | – | ﹤0.01% | 1945 |
|
|
2021
Q3 | $263K | Sell |
12,675
-3,394
| -21% | -$81.6K | ﹤0.01% | 1882 |
|
|
2021
Q2 | $558K | Buy |
16,069
+1,044
| +7% | +$21.9K | 0.01% | 1459 |
|
|
2021
Q1 | $262K | Sell |
15,025
-789
| -5% | -$14.3K | ﹤0.01% | 1828 |
|
|
2020
Q4 | $281K | Buy |
15,814
+689
| +5% | +$11.4K | ﹤0.01% | 1715 |
|
|
2020
Q3 | $235K | Sell |
15,125
-5,622
| -27% | -$99.4K | ﹤0.01% | 1683 |
|
|
2020
Q2 | $343K | Hold |
20,747
| – | – | 0.01% | 1468 |
|
|
2020
Q1 | $132K | Buy |
20,747
+83
| +0.4% | +$588 | ﹤0.01% | 1858 |
|
|
2019
Q4 | $147K | Sell |
20,664
-589
| -3% | -$3.59K | ﹤0.01% | 2109 |
|
|
2019
Q3 | $95.6K | Hold |
21,253
| – | – | ﹤0.01% | 2325 |
|
|
2019
Q2 | $147K | Buy |
21,253
+2,327
| +12% | +$16.5K | ﹤0.01% | 2099 |
|
|
2019
Q1 | $136K | Sell |
18,926
-2,120
| -10% | -$19.2K | ﹤0.01% | 2137 |
|
|
2018
Q4 | $208K | Hold |
21,046
| – | – | ﹤0.01% | 1795 |
|
|
2018
Q3 | $251K | Hold |
21,046
| – | – | ﹤0.01% | 1853 |
|
|
2018
Q2 | $195K | Buy |
21,046
+1,981
| +10% | +$17.8K | ﹤0.01% | 1961 |
|
|
2018
Q1 | $151K | Sell |
19,065
-190
| -1% | -$1.6K | ﹤0.01% | 2066 |
|
|
2017
Q4 | $190K | Sell |
19,255
-29,296
| -60% | -$317K | ﹤0.01% | 1939 |
|
|
2017
Q3 | $569K | Hold |
48,551
| – | – | ﹤0.01% | 1600 |
|
|
2017
Q2 | $827K | Hold |
48,551
| – | – | 0.01% | 1357 |
|
|
2017
Q1 | $739K | Hold |
48,551
| – | – | 0.01% | 1398 |
|
|
2016
Q4 | $787K | Sell |
48,551
-1,335
| -3% | -$24.6K | 0.01% | 1431 |
|
|
2016
Q3 | $1.02M | Hold |
49,886
| – | – | 0.01% | 1268 |
|
|
2016
Q2 | $1.04M | Buy |
49,886
+1,006
| +2% | +$18K | 0.01% | 1234 |
|
|
2016
Q1 | $1M | Hold |
48,880
| – | – | 0.01% | 1178 |
|
|
2015
Q4 | $826K | Sell |
48,880
-2,118
| -4% | -$31.2K | 0.01% | 1287 |
|
|
2015
Q3 | $661K | Hold |
50,998
| – | – | ﹤0.01% | 1445 |
|
|
2015
Q2 | $650K | Sell |
50,998
-2,421
| -5% | -$27.9K | ﹤0.01% | 1577 |
|
|
2015
Q1 | $523K | Hold |
53,419
| – | – | ﹤0.01% | 1536 |
|
|
2014
Q4 | $389K | Hold |
53,419
| – | – | ﹤0.01% | 1941 |
|
|
2014
Q3 | $388K | Hold |
53,419
| – | – | ﹤0.01% | 1889 |
|
|
2014
Q2 | $597K | Sell |
53,419
-8,294
| -13% | -$98K | ﹤0.01% | 1708 |
|
|
2014
Q1 | $693K | Buy |
61,713
+320
| +0.5% | +$3.29K | ﹤0.01% | 1589 |
|
|
2013
Q4 | $637K | Sell |
61,393
-5,899
| -9% | -$52.7K | ﹤0.01% | 1634 |
|
|
2013
Q3 | $568K | Hold |
67,292
| – | – | ﹤0.01% | 1680 |
|
|
2013
Q2 | $516K | Buy |
+67,292
| New | +$469K | ﹤0.01% | 1672 |
|
Other funds holding SWBI
PCM
Metropolitan Life Insurance Company (MetLife)'s SWBI Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Smith & Wesson (SWBI) in Q2 2024, closing a stake of 2,524 shares — an estimated $43.8K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in SWBI in Q2 2013 and held it in 44 quarters. The position peaked at $1.04M in Q2 2016. 194 funds tracked by Wall St. Rank hold SWBI as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Smith & Wesson position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,524 Smith & Wesson shares in Q2 2024, an estimated $43.8K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Smith & Wesson in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Smith & Wesson position peaked at $1.04M in Q2 2016.
- 194 funds tracked by Wall St. Rank held Smith & Wesson as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.